middle.news
Cleo Diagnostics Accelerates U.S. Trials and Boosts Cash Ahead of FDA Submission
3:25pm on Friday 31st of January, 2025 AEDT
•
Healthcare
Read Story
Cleo Diagnostics Accelerates U.S. Trials and Boosts Cash Ahead of FDA Submission
3:25pm on Friday 31st of January, 2025 AEDT
Key Points
Ongoing patient recruitment in U.S. clinical trials with expansion plans
Australian trial broadened to include Royal Women’s Hospital and Siles Health
On track for FDA submission of ovarian cancer diagnostic blood test
Appointment of new Head of Operations with manufacturing expertise
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Cleo Diagnostics (ASX:COV)
OPEN ARTICLE